GRP logo
Multi-Criteria Decision Analysis in Health Care Decision Making

Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

The citation for this report is:
Thokala P, Devlin, N, Marsh K, et al. Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 2016;19:1-13.

Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

The citation for this report is:
Marsh K, IJzerman M, Thokala P, et al. Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value Health 2016;19:125-137.

Editorial: Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
Andrew Walker, Health Economist, Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK

Co-Chairs:
Nancy Devlin, PhD, Director of Research, Office of Health Economics, London, UK
Maarten J. IJzerman, PhD, Professor of Clinical Epidemiology & Health Technology Assessment (HTA) and Head, Department of Health Technology & Services Research, University of Twente, Enschede, The Netherlands
Kevin Marsh, PhD, Senior Research Scientist and Senior Director of Modelling and Simulation, Evidera, London, UK
Praveen Thokala, MASc, PhD, Research Fellow, University of Sheffield, Sheffield, UK

Leadership Group
Meindert Boysen, MSc, Programme Director Technology Appraisals, PASLU and HST, National Institute for Health and Clinical Excellence (NICE),
Manchester, UK
Zoltán Kaló, MSc, MD, PhD, Professor of Health Economics, Department of Health Policy and Health Economics, Eötvös Loránd University (ELTE), Founder & CEO, Syreon Research Institute, Budapest, Hungary 
Thomas Lönngren, MSc(Pharm), Strategic Advisor, NDA Group AB, UK and Sweden
Filip Mussen, MSc, PhD, Vice-President, Regional Regulatory Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Antwerp, Belgium
Stuart Peacock, MSc, PhD, Co-Director, Canadian Centre for Applied Research in Cancer Control (ARCC), Deputy Head of Cancer Control Research, British Columbia Cancer Agency, and Professor, School of Population and Public Health, University of British Columbia, Vancouver, Canada
John Watkins, PharmD, MPH, BCPS, Pharmacy Manager, Formulary Development, Premera Blue Cross, Bothell, WA, USA

Activities

ISPOR MCDA Task Force: The Final Recommendations
November 2015 – 18th Annual European Congress, Third Plenary Presentation, Milan, Italy


Good Research Practices for Outcomes Research Index